8-KFiled Aug 31, 8:00 PM ET
BiomX Inc. Announces Name Change to Tessera Defense; Ticker to HLSQ
$PHGE · BiomX Inc.Research Summary
AI-generated summary of this SEC filing
BiomX Inc. Announces Name Change to Tessera Defense; Ticker to HLSQ
What Happened
- BiomX Inc. filed an 8-K on September 1, 2026, announcing its Board approved a corporate name change to Tessera Defense and Homeland Security Inc. on August 31, 2026. The company expects the name change to become effective at 12:01 a.m. Eastern Time on September 11, 2026, when its common stock will begin trading on the NYSE American under the new ticker symbol "HLSQ" (it will trade as "PHGE" until that time).
- The company also notes a previously announced one‑for‑ten reverse stock split that is expected to be effective September 9, 2026; CUSIP Global Services has confirmed the CUSIP number 09090D 608 will be assigned upon the reverse split and will not change due to the name change. The company will file a certificate of amendment with the Delaware Secretary of State; under Delaware law no stockholder vote is required.
Key Details
- Board approval date: August 31, 2026; 8‑K filed: September 1, 2026; name change effective: September 11, 2026 (12:01 a.m. ET).
- Ticker change: from "PHGE" to "HLSQ" at NYSE American market open on September 11, 2026.
- Reverse stock split: previously announced one‑for‑ten reverse split effective September 9, 2026; CUSIP 09090D 608 assigned upon split.
- No action required by stockholders; no exchange of certificates or book‑entry positions; name change does not affect stockholder rights.
Why It Matters
- The name and ticker change, combined with the reverse split, are administrative corporate actions that can affect how the stock appears and is traded (ticker symbol and per‑share price) but do not change shareholder rights or ownership percentages. Investors should expect the stock to trade under the new symbol HLSQ after the specified dates.
- Timing and processing are subject to regulatory and exchange procedures (NYSE American, DTC); the company includes forward‑looking statements noting these actions are subject to customary risks and timing uncertainties. Review the company’s filings and risk disclosures for more detail.